Donohue JF - Search Results

1

Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).

Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Hanania NA, et al. Among authors: donohue jf. Respir Med. 2010 Aug;104(8):1160-70. doi: 10.1016/j.rmed.2010.02.009. Epub 2010 Mar 11. Respir Med. 2010. PMID: 20226647 Free article.

2

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K. Donohue JF, et al. Treat Respir Med. 2004;3(3):173-81. doi: 10.2165/00151829-200403030-00005. Treat Respir Med. 2004. PMID: 15219176 Clinical Trial.

3

Role of bronchodilators in chronic obstructive pulmonary disease.

Weder MM, Donohue JF. Weder MM, et al. Among authors: donohue jf. Semin Respir Crit Care Med. 2005 Apr;26(2):221-34. doi: 10.1055/s-2005-869541. Semin Respir Crit Care Med. 2005. PMID: 16088439 Review.

4

Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.

Donohue JF, Ohar JA. Donohue JF, et al. Proc Am Thorac Soc. 2004;1(3):152-60. doi: 10.1513/pats.200402-003MS. Proc Am Thorac Soc. 2004. PMID: 16113428 Review.

5

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.

Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J; COPD Investigators. Rennard SI, et al. Among authors: donohue jf. Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. doi: 10.1164/rccm.200607-995OC. Epub 2007 Feb 8. Am J Respir Crit Care Med. 2007. PMID: 17290043 Clinical Trial.

6

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.

Hanania NA, Donohue JF. Hanania NA, et al. Among authors: donohue jf. Proc Am Thorac Soc. 2007 Oct 1;4(7):526-34. doi: 10.1513/pats.200701-016FM. Proc Am Thorac Soc. 2007. PMID: 17878465 Review.

7

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach J. Donohue JF, et al. Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010. Clin Ther. 2008. PMID: 18640474 Clinical Trial.

8

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.

Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JP. Donohue JF, et al. Ther Adv Respir Dis. 2008 Apr;2(2):37-48. doi: 10.1177/1753465808089455. Ther Adv Respir Dis. 2008. PMID: 19124357 Free article. Clinical Trial.

9

Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.

Donohue JF, Hanania NA, Fogarty C, Campbell SC, Rinehart M, Denis-Mize K. Donohue JF, et al. Ther Adv Respir Dis. 2008 Aug;2(4):199-208. doi: 10.1177/1753465808093934. Ther Adv Respir Dis. 2008. PMID: 19124372 Free article. Clinical Trial.

10

Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers.

Zhou H, Alexis NE, Almond M, Donohue J, LaForce C, Bromberg PA, Peden DB. Zhou H, et al. Respir Med. 2009 Sep;103(9):1358-65. doi: 10.1016/j.rmed.2009.03.007. Epub 2009 Apr 10. Respir Med. 2009. PMID: 19361972 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters